Basis: FMP quote market capitalization / four-quarter operating cash flow. Source: stored company filings and market data; unavailable inputs remain N/A.
The Price/OCF ratio is N/A as of 2026-10-06T21:58:26.242Z.
Calculation as of: 2026-10-06T21:58:26.242Z.
Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: c6190991d8493eebdba731817b981db063e7ae28b86b69413d904cae69ffb2ef
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PRICE/OCF RATIO
N/A
Market Cap
$48.76M
Price/OCF Ratio
N/A
TTM Avg
13.21
3Y Avg
14.20
5Y Avg
14.20
Market Cap
$48.89M
Price/OCF Ratio
N/A
TTM Avg
43.78
3Y Avg
43.71
5Y Avg
50.95
Market Cap
$49.25M
Price/OCF Ratio
N/A
TTM Avg
73.59
3Y Avg
628.92
5Y Avg
487.62
| NAME | MARKET CAP | PRICE/OCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| TELA Bio, Inc. (TELA) | $48.77M | N/A | N/A | N/A | N/A |
| Microbot Medical Inc. (MBOT)vs › | $48.76M | N/A | 13.21 | 14.20 | 14.20 |
| Sensus Healthcare, Inc. (SRTS)vs › | $48.89M | N/A | 43.78 | 43.71 | 50.95 |
| Apollomics, Inc. (APLM)vs › | $48.53M | N/A | N/A | N/A | N/A |
| Precision Optics Corporation, Inc. (POCI)vs › | $49.25M | N/A | 73.59 | 628.92 | 487.62 |
| Clene Inc. (CLNN)vs › | $49.45M | N/A | N/A | N/A | N/A |
| Lite Strategy, Inc. (LITS)vs › | $47.98M | N/A | N/A | N/A | N/A |
| INmune Bio, Inc. (INMB)vs › | $49.71M | N/A | N/A | N/A | N/A |
| Envoy Medical, Inc. (COCH)vs › | $50.27M | N/A | N/A | N/A | N/A |
| biote Corp. (BTMD)vs › | $50.28M | 2.06 | 2.08 | 4.49 | 3.97 |
P/OCF Ratio
N/A
P/FCF Ratio
N/A
P/OCF measures market price relative to operating cash flow: market cap divided by TTM operating cash flow. OCF is cash from operations before capital expenditures, so it sits above free cash flow — P/OCF typically reads below P/FCF, with the widest gap for capex-heavy businesses.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
